METHODS OF TREATING CARTILAGE GRAFTS WITH ALTERNATING ELECTRIC FIELDS
Disclosed are methods of treating a subject having a cartilage graft comprising applying alternating electric fields, at a frequency for a period of time, to a target site of the subject, wherein the target site comprises the cartilage graft. Disclosed are methods of increasing N-cadherin expression or promoting chondrogenesis in a subject having a cartilage graft comprising applying alternating electric fields, at a frequency for a period of time, to a target site of the subject. Disclosed are methods of upregulating the Akt/PI3K pathway in a subject having a cartilage graft comprising applying alternating electric fields, at a frequency for a period of time, to a target site of the subject.
1 . A method of treating a subject having a cartilage graft comprising:
applying alternating electric fields, at a frequency for a period of time, to a target site of the subject,
wherein the target site comprises the cartilage graft.
2 . The method of claim 1 , wherein the alternating electric fields promote chondrogenesis within the cartilage graft, thereby increasing the success rate of the cartilage graft.
3 . A method of increasing N-cadherin expression in a subject having a cartilage graft comprising:
applying alternating electric fields, at a frequency for a period of time, to a target site of the subject, wherein the target site comprises the cartilage graft,
thereby increasing N-cadherin expression at the target site in the subject.
4 . A method of promoting chondrogenesis in a subject having a cartilage graft comprising:
applying alternating electric fields, at a frequency for a period of time, to a target site of the subject, wherein the target site comprises the cartilage graft,
thereby promoting chondrogenesis in the subject.
5 . The method of claim 1 , wherein the cartilage graft is a scaffold that mimics articular cartilage or autologous chondrocyte implantation.
6 . The method of claim 1 , wherein the cartilage graft comprises mesenchymal stem cells.
7 . The method of claim 1 , wherein the subject received the cartilage graft at least 24 hours before applying the alternating electric fields.
8 . The method of claim 1 , further comprising administering an anti-inflammatory, an antibiotic, an osteoarthritis drug, or a pain management medication to the subject.
9 . The method of claim 1 , further comprising implanting the cartilage graft prior to applying the alternating electric fields.
10 . The method of claim 1 , wherein the subject does not have cancer or has not been diagnosed with cancer.
11 . The method of claim 1 , wherein the frequency of the alternating electric field is between 100 kHz and 10 MHz.
12 . The method of claim 1 , wherein the frequency of the alternating electric field is 210-400 KHz.
13 . The method of claim 1 , wherein the alternating electric field has a field strength of between 0.5 and 10 V/cm RMS.
14 . The method of claim 1 , wherein the alternating electric field has a field strength of 0.9 V/cm RMS.
15 . The method of claim 2 , further comprising ceasing application of the alternating electrical field once the subject is pain-free and/or has full mobility at the site of the cartilage graft.
16 . The method of claim 1 , wherein the Akt/PI3K pathway is upregulated.
17 . The method of claim 1 , wherein the target site is a joint, ear, nose, or breast.
18 . The method of claim 1 , wherein N-cadherin expression is increased at the target site.
19 . The method of claim 2 , wherein increasing the success rate of the cartilage graft is a quicker return to pain-free activities for the subject receiving the cartilage graft compared to a subject receiving a cartilage graft without an alternating electric field.
20 . The method of claim 1 , wherein the alternating electric field promotes chondrogenesis at the target site.